EP0671914A4 - - Google Patents

Info

Publication number
EP0671914A4
EP0671914A4 EP94903351A EP94903351A EP0671914A4 EP 0671914 A4 EP0671914 A4 EP 0671914A4 EP 94903351 A EP94903351 A EP 94903351A EP 94903351 A EP94903351 A EP 94903351A EP 0671914 A4 EP0671914 A4 EP 0671914A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP94903351A
Other versions
EP0671914A1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EP0671914A1 publication Critical patent/EP0671914A1/en
Publication of EP0671914A4 publication Critical patent/EP0671914A4/xx
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP94903351A 1992-12-01 1993-12-01 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds Ceased EP0671914A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98392092A 1992-12-01 1992-12-01
US983920 1992-12-01
PCT/US1993/011598 WO1994012178A1 (en) 1992-12-01 1993-12-01 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds

Publications (2)

Publication Number Publication Date
EP0671914A1 EP0671914A1 (en) 1995-09-20
EP0671914A4 true EP0671914A4 (en:Method) 1995-10-25

Family

ID=25530181

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94903351A Ceased EP0671914A1 (en) 1992-12-01 1993-12-01 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds

Country Status (8)

Country Link
EP (1) EP0671914A1 (en:Method)
JP (1) JPH08503711A (en:Method)
KR (1) KR950703950A (en:Method)
CN (1) CN1042795C (en:Method)
AU (1) AU673882B2 (en:Method)
CA (1) CA2150695A1 (en:Method)
WO (1) WO1994012178A1 (en:Method)
ZA (1) ZA938897B (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000510110A (ja) * 1996-04-29 2000-08-08 スミスクライン・ビーチャム・コーポレイション 抗酸化化合物
AU3542697A (en) * 1996-07-13 1998-02-09 Boehringer Mannheim Gmbh Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate
US6369106B1 (en) * 1996-12-26 2002-04-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
JPH10251147A (ja) * 1997-03-06 1998-09-22 Akira Matsumori 炎症性疾患の予防・治療剤
AR035455A1 (es) * 2001-04-23 2004-05-26 Hoffmann La Roche Derivados triciclicos de alquilhidroxamato , procesos para su elaboracion, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9412178A1 *

Also Published As

Publication number Publication date
CN1098908A (zh) 1995-02-22
AU5732394A (en) 1994-06-22
KR950703950A (ko) 1995-11-17
JPH08503711A (ja) 1996-04-23
AU673882B2 (en) 1996-11-28
ZA938897B (en) 1994-08-01
EP0671914A1 (en) 1995-09-20
WO1994012178A1 (en) 1994-06-09
CA2150695A1 (en) 1994-06-09
CN1042795C (zh) 1999-04-07

Similar Documents

Publication Publication Date Title
DK0634000T3 (en:Method)
TW242177B (en:Method)
DK0553875T3 (en:Method)
DK0551248T3 (en:Method)
TW247348B (en:Method)
TW222314B (en:Method)
TW265311B (en:Method)
DK0599160T3 (en:Method)
TW234221B (en:Method)
DK109593A (en:Method)
DK0644844T3 (en:Method)
DK0554977T3 (en:Method)
DK0553681T3 (en:Method)
DK0657012T3 (en:Method)
TW268000B (en:Method)
DK0648175T3 (en:Method)
DK113692D0 (en:Method)
DK0576097T3 (en:Method)
FR2688752B1 (en:Method)
DK0590732T3 (en:Method)
TW269016B (en:Method)
AU632452B2 (en:Method)
IN181048B (en:Method)
IN179351B (en:Method)
DK100792D0 (en:Method)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950606

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19950905

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19981117

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20010220

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1012248

Country of ref document: HK